Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
19 Dec 2019
Historique:
received: 23 07 2019
accepted: 20 11 2019
entrez: 21 12 2019
pubmed: 21 12 2019
medline: 2 6 2020
Statut: epublish

Résumé

Our objectives were (1) to characterize the distribution of serum potassium levels at ICU admission, (2) to examine the relationship between dyskalemia at ICU admission and occurrence of cardiac events, and (3) to study both the association between dyskalemia at ICU admission and dyskalemia correction by day 2 on 28-day mortality. Inception cohort study from the longitudinal prospective French multicenter OUTCOMEREA database (1999-2014) SETTING: 22 French OUTCOMEREA network ICUs PATIENTS: Patients were classified into six groups according to their serum potassium level at admission: three groups of hypokalemia and three groups of hyperkalemia defined as serious hypokalemia [K+] < 2.5 and serious hyperkalemia [K+] > 7 mmol/L, moderate hypokalemia 2.5 ≤ [K+] < 3 mmol/L and moderate hyperkalemia 6 < [K+] ≤ 7 mmol/L, and mild hypokalemia 3 ≤ [K+] < 3.5 mmol/L and mild hyperkalemia 5 < [K+] ≤ 6 mmol/L. We sorted evolution at day 2 of dyskalemia into three categories: balanced, not-balanced, and overbalanced. None MEASUREMENTS AND MAIN RESULTS: Of 12,090 patients, 2108 (17.4%) had hypokalemia and 1445 (12%) had hyperkalemia. Prognostic impact of dyskalemia and its correction was assessed using multivariate Cox models. After adjustment, hypokalemia and hyperkalemia were independently associated with a greater risk of 28-day mortality. Mild hyperkalemic patients had the highest mortality (hazard ratio (HR) 1.29, 95% confidence interval (CI) [1.13-1.47], p < 0.001). Adjusted 28-day mortality was higher if serum potassium level was not-balanced at day 2 (aHR = 1.51, 95% CI [1.30-1.76], p < 0.0001) and numerically higher but not significantly different if serum potassium level was overbalanced at day 2 (aHR = 1.157, 95% CI [0.84-1.60], p = 0.38). Occurrence of cardiac events was evaluated by logistic regression. Except for patients with serious hypokalemia at admission, the depth of dyskalemia was associated with increased risk of cardiac events. Dyskalemia is common at ICU admission and associated with increased mortality. Occurrence of cardiac events increased with dyskalemia depth. A correction of serum potassium level by day 2 was associated with improved prognosis.

Identifiants

pubmed: 31856891
doi: 10.1186/s13054-019-2679-z
pii: 10.1186/s13054-019-2679-z
pmc: PMC6921444
doi:

Substances chimiques

Potassium RWP5GA015D

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

415

Investigateurs

Jean-François Timsit (JF)
Elie Azoulay (E)
Maïté Garrouste-Orgeas (M)
Jean-Ralph Zahar (JR)
Christophe Adrie (C)
Michael Darmon (M)
Christophe Clec'h (C)
Corinne Alberti (C)
Adrien Français (A)
Aurélien Vesin (A)
Stephane Ruckly (S)
Sébastien Bailly (S)
Frederik Lecorre (F)
Didier Nakache (D)
Aurélien Vannieuwenhuyze (A)
Carole Agasse (C)
Bernard Allaouchiche (B)
Olivier Andremont (O)
Pascal Andreu (P)
Laurent Argaud (L)
Claire Ara Somohano (CA)
Francois Barbier (F)
Jean-Pierre Bedos (JP)
Jérome Bedel (J)
Julien Bohé (J)
Lila Bouadma (L)
Noel Brule (N)
Cédirc Brétonnière (C)
Christine Cheval (C)
Elisabeth Coupez (E)
Etienne de Montmollin (E)
Loa Dopeux (L)
Anne-Sylvie Dumenil (AS)
Claire Dupuis (C)
Jean-Marc Forel (JM)
Marc Gainnier (M)
Charlotte Garret (C)
Antoine Gros (A)
Akim Haouache (A)
Romain Hernu (R)
Samir Jamali (S)
Sébastien Jochmans (S)
Jean-Baptiste Joffredo (JB)
Hatem Khallel (H)
Guillaume Lacave (G)
Alexandre Lautrette (A)
Virgine Lemiale (V)
Mathilde Lermuzeaux (M)
Guillaume Marcotte (G)
Eric Le Miere (E)
Jordane Lebut (J)
Maxime Lugosi (M)
Eric Magalhaes (E)
Sibylle Merceron (S)
Bruno Mourvillier (B)
Benoît Misset (B)
Delphine Moreau (D)
Mathild Neuville (M)
Laurent Nicolet (L)
Laurent Papazian (L)
Benjamin Planquette (B)
Jean-Pierre Quenot (JP)
Aguila Radjou (A)
Romain Sonneville (R)
Jean Reignier (J)
Bertrand Souweine (B)
Carole Schwebel (C)
Roland Smonig (R)
Gilles Troché (G)
Marie Thuong (M)
Guillaume Thierry (G)
Dany Toledano (D)
Guillaume Van Der Meersch (G)
Marion Venot (M)
Olivier Zambon (O)
Julien Fournier (J)
Caroline Tournegros (C)
Stéphanie Bagur (S)
Mireille Adda (M)
Vanessa Vindrieux (V)
Sylvie de la Salle (S)
Loic Ferrand (L)
Stéphane Guessens (S)
Helene Merle (H)
Nadira Kaddour (N)
Boris Berthe (B)
Samir Bekkhouche (S)
Kaouttar Mellouk (K)
Mélaine Lebrazic (M)
Carole Ouisse (C)
Diane Maugars (D)
Sylvie Conrozier (S)
Igor Theodose (I)
Manal Nouacer (M)
Veronique Deiler (V)
Myriam Moussa (M)
Atika Mouaci Nassima Viguier (AMN)
Sophie Letrou (S)

Références

JAMA. 2012 Jan 11;307(2):157-64
pubmed: 22235086
Shock. 2014 May;41(5):394-9
pubmed: 24667611
Crit Care. 2015 Jan 06;19:4
pubmed: 25560457
N Engl J Med. 2001 Nov 8;345(19):1359-67
pubmed: 11794168
J Am Coll Cardiol. 2004 Jan 21;43(2):155-61
pubmed: 14736430
N Engl J Med. 2006 Feb 2;354(5):449-61
pubmed: 16452557
Rev Bras Ter Intensiva. 2008 Sep;20(3):296-304
pubmed: 25307098
Crit Care Med. 1991 Sep;19(9):1177-82
pubmed: 1909223
Intensive Care Med. 2012 Nov;38(11):1834-42
pubmed: 22806439
Crit Care Med. 1981 Aug;9(8):591-7
pubmed: 7261642
Crit Care. 2014 Dec 15;18(6):688
pubmed: 25498795
Crit Care Med. 1993 Jun;21(6):901-6
pubmed: 8504660
Kidney Int. 2007 Aug;72(3):247-59
pubmed: 17568785
Nephrol Dial Transplant. 2008 Dec;23(12):3939-45
pubmed: 18614817
N Engl J Med. 2009 Mar 26;360(13):1283-97
pubmed: 19318384
N Engl J Med. 1998 Aug 13;339(7):451-8
pubmed: 9700180
Nephrol Dial Transplant. 2010 Aug;25(8):2510-5
pubmed: 20167570
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Crit Care. 2013 Jan 21;17(1):R12
pubmed: 23336363
Crit Care Clin. 2002 Apr;18(2):273-88, vi
pubmed: 12053834

Auteurs

Lila Bouadma (L)

UMR 1137, IAME, Université Paris Diderot, F75018, Paris, France. lila.bouadma@bch.aphp.fr.
Medical and Infectious Diseases Care Unit, AP-HP, Bichat University Hospital, F75018, Paris, France. lila.bouadma@bch.aphp.fr.
Service de Réanimation Médicale et des Maladies Infectieuses, Hôpital Bichat-Claude-Bernard, 46 rue Henri-Huchard, 75877, Paris Cedex 18, France. lila.bouadma@bch.aphp.fr.

Stefan Mankikian (S)

AP-HP, Pitié-Salpêtrière University Hospital, Cardiology, Paris, France.

Michael Darmon (M)

APHP, Saint-Louis University Hospital, Medical Intensive Care Unit, Paris, France.
Paris-7 Paris Diderot University, Paris, France.

Laurent Argaud (L)

Medical ICU, Edouard Herriot University Hospital, Lyon, France.

Camille Vinclair (C)

UMR 1137, IAME, Université Paris Diderot, F75018, Paris, France.

Shidasp Siami (S)

Critical Care Medicine Unit CH Etampes-Dourdan, Etampes, France.

Maité Garrouste-Orgeas (M)

Medical Unit, French British Hospital Institute, Levallois-Perret, France.

Laurent Papazian (L)

Respiratory and Infectious Diseases ICU, APHM Hôpital Nord, Aix Marseille University, Marseille, France.

Yves Cohen (Y)

AP-HP, Avicenne Hospital, Intensive Care Unit, Paris, France.
Medicine University, Paris 13 University, Bobigny, France.

Guillaume Marcotte (G)

Surgical Intensive Care Unit and Lyon University Hospital, Lyon, France.

Lenka Styfalova (L)

OUTCOMEREA organization, F75018, Paris, France.

Jean Reignier (J)

Medical Intensive Care Unit and University Hospital Centre, Nantes, France.

Alexandre Lautrette (A)

Medical Intensive Care Unit, Gabriel Montpied University Hospital, Clermont-Ferrand, France.

Carole Schwebel (C)

Medical Intensive Care Unit, Grenoble University Hospital, Grenoble 1 University, U823, La Tronche, France.

Jean-Francois Timsit (JF)

UMR 1137, IAME, Université Paris Diderot, F75018, Paris, France.
Medical and Infectious Diseases Care Unit, AP-HP, Bichat University Hospital, F75018, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH